| BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 卷:25 |
| Interfacial inhibitors | |
| Article | |
| Pommier, Yves1  | |
| [1] NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA | |
| 关键词: Topoisomerase; Integrase; Chemotherapy; Natural products; Pharmacology; | |
| DOI : 10.1016/j.bmcl.2015.07.032 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Targeting macromolecular interface is a general mechanism by which natural products inactivate macromolecular complexes by stabilizing normally transient intermediates. Demonstrating interfacial inhibition mechanism ultimately relies on the resolution of drug-macromolecule structures. This review focuses on medicinal drugs that trap protein-DNA complexes by binding at protein-DNA interfaces. It provides proof-of-concept and detailed structural and mechanistic examples for topoisomerase inhibitors and HIV integrase inhibitors. Additional examples of recent interfacial inhibitors for protein-DNA interfaces are provided, as well as prospects for targeting previously 'undruggable' targets including transcription, replication and chromatin remodeling complexes. References and discussion are included for interfacial inhibitors of protein-protein interfaces. Published by Elsevier Ltd.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_bmcl_2015_07_032.pdf | 662KB |
PDF